Cite
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
MLA
Zou, Zhaowei, et al. “Nuclear MiR-204-3p Mitigates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.” Journal of Hepatology, vol. 80, no. 6, June 2024, pp. 834–45. EBSCOhost, https://doi.org/10.1016/j.jhep.2024.01.029.
APA
Zou, Z., Liu, X., Yu, J., Ban, T., Zhang, Z., Wang, P., Huang, R., Zheng, F., Chang, Y., Peng, W., Tang, Y., Feng, X., Zhao, Z., Lv, X., Huang, S., Guo, J., Tuo, Y., Zhou, Z., & Liang, S. (2024). Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice. Journal of Hepatology, 80(6), 834–845. https://doi.org/10.1016/j.jhep.2024.01.029
Chicago
Zou, Zhaowei, Xiu Liu, Jie Yu, Tao Ban, Ziyi Zhang, Peiqi Wang, Renli Huang, et al. 2024. “Nuclear MiR-204-3p Mitigates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.” Journal of Hepatology 80 (6): 834–45. doi:10.1016/j.jhep.2024.01.029.